资讯

Morepen gets regulatory clearance for fatty liver drug development
Morepen Laboratories gains CDSCO approval for Resmetirom bioequivalence studies, positioning the company for global NASH ...
Morepen receives CDSCO nod to conduct BE studies for Resmetirom
Morepen Laboratories has got clearance from Subject Expert Committee (SEC) of Central Drugs Standard Control Organization (CDSCO) to conduct Bioequivalence (BE) studies for Resmetirom 60 mg, 80 mg and ...